Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people’s lives. We pioneer novel approaches to drive access to medicine. Our portfolio comprises over 1000 molecules and our products reach more than 500 million patients.
Sandoz is also on Twitter. Follow us on @Sandoz_global
Contact Details
Tags
access to medicine#makingaccesshappen#sandozhackbiosimilarsmedicine#medmeesandozhealthcarecancerhealthhelthcare#access4allsandoz hack - healthcare access challenge#gopharmapharamcy#blooddrive#sali#pilldrop
We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.